Dechra Pharmaceuticals Appointments Two New Independent Non Executive Directors

Dechra is pleased to announce the appointment of two Independent Non Executive Directors: Julian Heslop (to be appointed on 1 January 2013) and Ishbel Macpherson (to be appointed 1 February 2013). Julian Heslop Julian served as Chief Financial Officer of GlaxoSmithKline PLC between 2005 and 2011, having previously been appointed its Senior Vice President, Operations Controller between 2001 and 2005 and as Financial Controller of Glaxo Wellcome PLC between 1998 and 2000. Prior to this, Julian had senior finance roles at Grand Metropolitan PLC and Imperial Brewing and Leisure. He is a Fellow of the Institute of Chartered Accountants in England and Wales. Julian was appointed as a Non Executive Director at Revolymer PLC in July 2012 and is their Audit Committee Chairman. He is also Chairman of the Audit Committee of the Royal Academy of Arts. Ishbel Macpherson Ishbel is currently Non Executive Chairman of Speedy Hire PLC, a position which she has held since January 2011 (having been appointed to the Board of Speedy Hire in 2007). Ishbel also holds Non Executive Directorships at Synthomer PLC (formerly Yule Catto & Co plc), May Gurney Integrated Services plc and Dignity plc. Ishbel has over 20 years’ experience as an investment banker, specialising in UK mid-market corporate finance. She was Head of UK Emerging Companies Corporate Finance at DresdnerKleinwort Wasserstein from 1999 to 2005, having previously worked at Hoare Govett and Barclays. Ishbel and Julian will both be members of the Group’s Audit, Remuneration and Nomination Committees with the intention that Julian will be appointed as Chairman of the Audit Committee upon Neil Warner’s retirement at the 2013 AGM. There are no other matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules in relation to either of these appointments. Commenting on the appointments, Mike Redmond, Chairman of Dechra said: “On behalf of the Board, I welcome Ishbel and Julian to Dechra. Each brings a wealth of relevant experience with them which will be valuable as we take Dechra on to the next stage. We look forward to working with them."

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause